Sign in

CIK 0002093101

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Atrium Therapeutics, Inc.

Sign in to watch
Ticker
RNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
394639499
Phone
+1 619-876-0700
Business address
10578 SCIENCE CENTER DRIVE, SUITE 125, SAN DIEGO, CA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-09-18 Flanagan W. Michael Director Shares withheld for taxes −22,812 $8.95 $204K 31,974
2026-02-27 Flanagan W. Michael Director Grant or award · Stock Option (Right to Buy) +20,000 20,000

Page 1 of 1 · 2 trades